Twist Bioscience Corporation (TWST) Cash Flow Statement
Twist Bioscience Corporation (TWST) generated -$53.1M of operating cash flow over the twelve months to 2026-06-30, spent $45.1M on capital expenditure and had free cash flow of -$98.1M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TWSTTwist Bioscience CorporationFollow TWST — free
—
Price chart with a free account
- Market cap
- 8.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 13 Nov, in 20 days
| Line | FY2019 Sep 19 | FY2020 Sep 20 | FY2021 Sep 21 | FY2022 Sep 22 | FY2023 Sep 23 | FY2024 Sep 24 | FY2025 Sep 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -87.9 | -142.3 | -112.2 | -124.4 | -142.5 | -64.1 | -47.6 | -53.1 | |
| Capital expenditure | 14.8 | 9.9 | 27.1 | 101.9 | 27.8 | 5.1 | 28.0 | -45.1 | |
| Free cash flow | -102.7 | -152.1 | -139.3 | -226.2 | -170.3 | -69.2 | -75.6 | -98.1 | |
| Stock-based compensation | 11.2 | 17.1 | 37.0 | 79.7 | 30.3 | 50.9 | 64.5 | — |
USD millions · SEC XBRL
Twist Bioscience Corporation — questions
- What is Twist Bioscience Corporation's operating cash flow?
- -$53.1M over the twelve months to 2026-06-30.
- How much does Twist Bioscience Corporation spend on capital expenditure?
- $45.1M over the twelve months to 2026-06-30.
- What is Twist Bioscience Corporation's free cash flow?
- -$98.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Twist Bioscience Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.